• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY:JNJ)

    241.53 +1.12 (+0.47%)
    Streaming Delayed Price Updated: 9:38 AM EDT, Mar 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 388,928
    Open 240.87
    Bid (Size) 241.26 (100)
    Ask (Size) 241.61 (100)
    Prev. Close 240.40
    Today's Range 240.41 - 242.76
    52wk Range 141.50 - 251.71
    Shares Outstanding 2,628,679,824
    Dividend Yield 2.15%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Quiet Outperformance From an Overlooked Dividend ETF ↗
    Via MarketBeat
    News headline image
    2 No-Brainer Dividend Stocks to Buy in 2026 ↗
    Their futures look bright, and their dividends are safe. 
    Via The Motley Fool
    Topics Intellectual Property

    Performance

    YTD
    +16.5%
    +16.5%
    1 Month
    +0.6%
    +0.6%
    3 Month
    +19.8%
    +19.8%
    6 Month
    +35.6%
    +35.6%
    1 Year
    +44.0%
    +44.0%

    More News

    Read More
    News headline image
    These 7 Elite Dividend Stocks Pay $114 Billion Annually, Combined, to Their Shareholders ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    Johnson & Johnson (NYSE:JNJ): A Dividend King Built for Sustainable Passive Income ↗
    Via Chartmill
    News headline image
    FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results ↗
    Via Benzinga
    News headline image
    Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion
    Via FinancialNewsMedia
    News headline image
    2 Top Defensive ETFs That Prioritize Stability Over Excitement ↗
    Via The Motley Fool
    Topics Artificial Intelligence ETFs World Trade
    News headline image
    ImmunityBio (IBRX) Shares Plummet Despite Piper Sandler Price Target Hike and 700% Revenue Growth
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
    Via MarketMinute
    Topics Artificial Intelligence Economy World Trade
    News headline image
    Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
    From Johnson & Johnson
    Via Business Wire
    News headline image
    How to Spot Winning Innovation ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Middleby Is Spinning Off Its Food Processing Segment After a $540 Million Asset Sale. Can the Breakup Close Its Valuation Gap? ↗
    Via The Motley Fool
    News headline image
    2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash ↗
    Via The Motley Fool
    News headline image
    Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
    Via Finterra
    Topics Earnings Economy Intellectual Property
    News headline image
    ACR Alpine Capital Research Buys 1 Million Shares of Arrow Electronics Stock ↗
    Via The Motley Fool
    News headline image
    Boring Is Beautiful: Why Johnson & Johnson Is Beating the Tech Sector ↗
    Via MarketBeat
    News headline image
    Is Johnson & Johnson Stock Outperforming the Nasdaq?
    Via Barchart.com
    Topics Stocks World Trade
    News headline image
    Kenvue Defies Market Headwinds with Q4 Earnings Beat as Kimberly-Clark Merger Looms
    Via MarketMinute
    Topics Earnings Economy World Trade
    News headline image
    Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio ↗
    Via The Motley Fool
    Topics Retirement
    News headline image
    The Only Healthcare Stock I'd Buy and Never Sell Might Be Johnson & Johnson ↗
    Via The Motley Fool
    News headline image
    Economic Stagnation: Q4 2025 GDP Misses Mark as Government Shutdown Hangs Heavy Over 2026 Outlook
    Via MarketMinute
    Topics Earnings Economy
    Friday's session: gap up and gap down stock in the S&P500 index ↗
    Via Chartmill
    News headline image
    JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B ↗
    Via Stocktwits
    News headline image
    Health Care Sector (XLV) Shows Resilience Amid Tech Volatility and Strong Jobs Data
    Via MarketMinute
    Topics Artificial Intelligence ETFs Earnings
    News headline image
    Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
    From Johnson & Johnson
    Via Business Wire

    Frequently Asked Questions

    Is Johnson & Johnson publicly traded?
    Yes, Johnson & Johnson is publicly traded.
    What exchange does Johnson & Johnson trade on?
    Johnson & Johnson trades on the New York Stock Exchange
    What is the ticker symbol for Johnson & Johnson?
    The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
    What is the current price of Johnson & Johnson?
    The current price of Johnson & Johnson is 241.53
    When was Johnson & Johnson last traded?
    The last trade of Johnson & Johnson was at 03/09/26 09:38 AM ET
    What is the market capitalization of Johnson & Johnson?
    The market capitalization of Johnson & Johnson is 634.89B
    How many shares of Johnson & Johnson are outstanding?
    Johnson & Johnson has 635B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.